Biosimilar switching – current state of knowledge

Evidence from over 10 years of clinical experience demonstrates that biosimilar medicines approved in the European Union can be used for all their registered indications as safely as their originators and with no negative impact on therapeutic efficacy. The debate on the use of biosimilars in rheuma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Reumatologia
Main Authors: Wiland, Piotr, Batko, Bogdan, Brzosko, Marek, Kucharz, Eugeniusz J., Samborski, Włodzimierz, Świerkot, Jerzy, Więsik-Szewczyk, Ewa, Feldman, Julia
Format: Artigo
Sprog:Inglês
Udgivet: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Fag:
Review Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142020/
https://ncbi.nlm.nih.gov/pubmed/30237628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2018.77975
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker